Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The EMPOWER Trial: Evaluating a Home-Based Physical Activity Program (PAP) With the ExerciseRx™ Digital Platform vs. Health Education Group (HEG) in People With Non-Muscle Invasive Bladder Cancer

NCT07302230 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT07302230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07302230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The EMPOWER Trial: Evaluating a Home-Based Physical Activity Program (PAP) With the ExerciseRx™ Digital Platform vs. Health Education Group (HEG) in People With Non-Muscle Invasive Bladder Cancer
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Recruiting
Start date
March 11, 2026
Completion date
September 27, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized non-muscle invasive bladder urothelial carcinoma, stage 0a bladder cancer ajcc v8, stage 0is bladder cancer ajcc v8, stage i bladder cancer ajcc v8